Congruency between clinician-assessed risk and calculated risk of 1-year mortality in patients with pulmonary arterial hypertension: A retrospective chart review

The objective of this analysis was to compare clinician-based and formally calculated risk assessments by REVEAL Lite 2 and COMPERA 2.0 and to characterize parenteral prostacyclin utilization within 90 days of baseline in high-risk patients. A multisite, double-blind, retrospective chart review of p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pulmonary circulation 2024-10, Vol.14 (4), p.e12455-n/a
Hauptverfasser:	Raina, Amresh, Sketch, Margaret R, Wu, Benjamin, Broderick, Meredith, Shlobin, Oksana A
Format:	Artikel
Sprache:	eng
Schlagworte:	COMPERA Mortality Patients prostacyclin Pulmonary hypertension REVEAL Lite 2 Risk assessment treprostinil
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!